Table 1.
Characteristic | No. | (%) |
---|---|---|
Sex | ||
Male | 212 | (66.5) |
Female | 105 | (33) |
Not known | 2 | (<1) |
Cirrhosis (n = 131)a | ||
No decompensation | 53 | (40.5) |
Decompensated | 42 | (32) |
HCC | 25 | (19) |
Decompensated + HCC | 11 | (8.5) |
Probable source of infection (N = 319) | ||
Born abroad | 127 | (40) |
Blood/blood product | 54b | (17) |
Injection drug use | 33 | (10) |
Known HCV-positive partner | 6 | (2) |
Perinatal exposure | 1 | (<0.1) |
Other | 44 | (14) |
No known risk factor | 29 | (9) |
Data incomplete | 7 | (2) |
No data entry | 18 | (5.5) |
Abbreviations: HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
aStratification of HCV-infected cases with cirrhosis by disease type.
bFor 2 individuals, country of birth was recorded as the likely location for acquiring infection.